Krka d d : Reports January to September 2023 Business Results
November 16, 2023 at 03:18 am EST
Share
HomeMedia centerNewsKrka Reports January to September 2023 Business Results
16. 11. 2023
Krka Reports January to September 2023 Business Results
2 min. read
In the first nine months of 2023 Krka Group revenue amounted to €1,340.5 million, up 8% year-on-year, resulting in €320.3 million of operating profit for the period - the highest to date. Net profit totalled €235.6 million. The Krka Supervisory Board discussed the January to September 2023 interim report for the Krka Group and Krka, d. d., at its regular meeting yesterday.
The President of the Management Board and Chief Executive Jože Colarič stated: "The Krka Group business was successful. Sales increased in all six sales regions and in most markets. In the first nine months, we recorded the highest operating profit (EBIT) to date, which increased by 37%. According to forecasts the Krka Group will exceed the annual 2023 sales target, reporting 1,770 million euros of product and services sales and a net profit of around 300 million euros.
Krka Group Financial Highlights
€ thousand
Jan-Sept 2023
Jan-Sept 2022
Index
Revenue
1,340,536
1,242,203
108
- Of that revenue from contracts with customers (products and services)
1,334,881
1,236,531
108
Gross profit
771,216
681,132
113
Earnings before interest, tax, depreciation and amortisation (EBITDA)
398,235
314,192
127
Operating profit (EBIT)
320,274
233,784
137
Profit before tax (EBT)
286,610
356,189
80
Net profit
235,559
301,668
78
R&D expenses
127,344
119,481
107
Investments
81,454
74,924
109
Performance Ratios
Jan-Sept 2023
Jan-Sept 2022
Gross profit margin
57.5%
54.8%
EBITDA margin
29.7%
25.3%
EBIT margin
23.9%
18.8%
EBT margin
21.4%
28.7%
Net profit margin (ROS)
17.6%
24.3%
Return on equity (ROE)
14.8%
19.9%
Return on assets (ROA)
11.8%
15.3%
Liabilities/Equity
0.253
0.282
R&D expenses/Revenue
9.5%
9.6%
Sales
Product and Service Sales by Region
Region Slovenia,6.5
Region South-East Europe,14.0
Region East Europe,32.5
Region Central Europe,22.8
Region West Europe,20.0
Region Overseas Markets,4.2
RELATED CONTENT
Press release: Krka Reports January to September 2023 Business Results (16. 11. 2023)
Unaudited interim report of the Krka Group and Krka for the period January to September 2023
KRKA dd published this content on 16 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2023 08:16:06 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
